TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05930951 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05930951 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05768139 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05768139 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05768139 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05118178 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT06135818 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT06135818 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05894239 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05894239 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05732077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05687760 — Surrogate Endpoint (SUR): Bacterial count
Study NCT06338605 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06338605 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT06201520 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study NCT05113004 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study NCT04121481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04860960 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study NCT04931420 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06005506 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05929326 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05645679 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05826184 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05867719 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT05867719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04896021 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05622643 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT05622643 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04681287 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05464082 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05575804 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04819750 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06293898 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06007430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06007430 — Safety Biomarker (SAF): Interleukin 1
Study NCT05536505 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06469658 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06387238 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06483074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06259227 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06259227 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05882292 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05882292 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT06628687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06443281 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05042986 — Predictive Biomarker (PRD): SKI mRNA
Genes: SKI
Study NCT06575452 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT06232122 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02735083 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04605055 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT05652920 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT04542291 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06605066 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06605066 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT06663046 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06658132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06051487 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05647551 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05956210 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06730984 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT04707352 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06033508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06033508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06034132 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT04988607 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05600764 — Predictive Biomarker (PRD): TRPV4 mRNA
Genes: TRPV4; VRL2; VROAC
Study NCT04749108 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06503796 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05555030 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05498064 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05885776 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05885776 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06340737 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06340737 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT05366296 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05507827 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05507827 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06701812 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT05741034 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05411133 — Predictive Biomarker (PRD): CDH17 mRNA
Genes: CDH17
Study NCT05435248 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04364672 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT03989167 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT06519110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05232071 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04967755 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05480878 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT05480878 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05354063 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05535673 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06470672 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06470672 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06470672 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06315140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06051695 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT06051695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06025201 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study NCT05736731 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05736731 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05911958 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05911958 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05640102 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05805202 — Predictive Biomarker (PRD): DGKE mRNA
Genes: DGKE; DAGK5
Study NCT05720702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05831891 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05831891 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04905914 — Predictive Biomarker (PRD): ATRN mRNA
Genes: ATRN; KIAA0548; MGCA
Study NCT06031675 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06031675 — Predictive Biomarker (PRD): GSDMD mRNA
Genes: GSDMD; DFNA5L; GSDMDC1; FKSG10
Study NCT06512766 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study NCT05729100 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04871321 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT04232501 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06131645 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04751331 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00000819 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05715801 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05339009 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT06248593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06554496 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT05870007 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT05870007 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT05248932 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04770272 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04718220 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00050921 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06665594 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05279469 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05574114 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05475613 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06281678 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06291155 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06005493 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT06114056 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06622304 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06622304 — Predictive Biomarker (PRD): NPC1L1 mRNA
Genes: NPC1L1
Study NCT06622304 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06622304 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06622304 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04593498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06047886 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06671769 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04875234 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05853575 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04346394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06624423 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05958303 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05257473 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT06274801 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05732623 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04877184 — Safety Biomarker (SAF): BDNF
Study NCT05232578 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT05291923 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05291923 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05465174 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06671262 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06671262 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06355739 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06692764 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06692764 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05120349 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06743503 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06744075 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05725148 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06765109 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04763616 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04763616 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06764888 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT05266274 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05635643 — Predictive Biomarker (PRD): CCR8 mRNA
Genes: CCR8; CKRL1; CMKBR8; CMKBRL2
Study NCT06347016 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT06347016 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06769035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06769035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04777032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04777032 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04957784 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05821179 — Predictive Biomarker (PRD): miR-106a
Genes: MIR106A
Study NCT03905109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05815043 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04843852 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT05128773 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05128773 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04901676 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04901676 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT05378659 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05378659 — Safety Biomarker (SAF): Interleukin 1
Study NCT06364696 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05327751 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05552157 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05468138 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05090358 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05090358 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05366933 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05685602 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05685602 — Safety Biomarker (SAF): Interleukin 1
Study NCT06230458 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00000977 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04462692 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT05411380 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05411380 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05411380 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05411380 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06553963 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05353556 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06145490 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study NCT06145490 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT00650390 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06130956 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04715607 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05599347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05135663 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05621083 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05621083 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03690011 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT03690011 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT06419179 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05936229 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05350501 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06236243 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06649838 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05259046 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03901534 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03901534 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT03901534 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT03901534 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06608472 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04517656 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT06575621 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05767528 — Predictive Biomarker (PRD): Protein patched homolog 1
Genes: PTCH1; PTCH
Study NCT04726267 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04726267 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06513221 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT05553379 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05891561 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04755738 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04644575 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04644575 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT06707012 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06710652 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06708871 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06708871 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06745063 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06744660 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06745687 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06673381 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06744504 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT06744504 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study NCT06744504 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MYH11 mRNA
Genes: MYH11; KIAA0866
Study NCT05767996 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04860817 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06029816 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05615142 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05653791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05769751 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04409080 — Predictive Biomarker (PRD): IL2RG mRNA
Genes: IL2RG
Study NCT04409080 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05954715 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04913766 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04132882 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT04925206 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04110262 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05306977 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06644560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06644560 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06644560 — Predictive Biomarker (PRD): NOS2 mRNA
Genes: NOS2; NOS2A
Study NCT05040178 — Surrogate Endpoint (SUR): Plasma ammonia
Study NCT05466149 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05466149 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF